The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol. 2008;15:3866–71. CentralHaas GP, Delongchamps N, Brawley OW, Wang CY, de la Roza G (2008) The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J U...
Annual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are projected to increase by 85% to almost 700,000 over the same timeframe—mainly among men in low- and middle-income countries. Acommissioned report publishedinThe Lancethighlights the future la...
Prostate cancer is a complex disease that affects millions of men globally, predominantly in high human development index regions. Patients with localized disease at a low to intermediate risk of recurrence generally have a favourable outcome of 99% over
cancer (OR: 1.28, p < 0.001) and specifically for significant prostate cancer (OR: 1.46, p < 0.001) in uni-variate analyses. However, multi-variate analyses using age, PSA, prostate volume, DRE and transrectal ultrasonography outcome, and previous biopsy (yes/no) showed that PSAV was not ...
FullText The number of people diagnosed with prostate cancer will more than double worldwide over the next 2 decades, from 1.4 million in 2020 to 2.9 million by 2040, according tofindingsfrom aLancetCommission. More people will also die from the condition, with an estimated 700 000 ...
Prostate cancer Cancer of the prostate is the second most common cancer diagnosed worldwide (after breast cancer), with 889,102 cases diagnosed in 2008 (Chisholm, McCabe, Wootten, & Abbott, 2012). Since the survival rate ofprostate canceris high, quality of life issues have become very import...
Read about prostate cancer symptoms, treatment, survival rates, stages, surgery, screening, causes and diagnosis. Learn lifestyle strategies to reduce the risk of prostate cancer.
FullText The number of people diagnosed with prostate cancer will more than double worldwide over the next 2 decades, from 1.4 million in 2020 to 2.9 million by 2040, according tofindingsfrom aLancetCommission. More people will also die from the condition, with an estimated 700 000 ...
Prostate cancer, Incidence, Mortality, Epidemiological distribution, China References [1] Bray F, Ferlay J, Soerjomataram I,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-...
In conclusion, three second-generation AR antagonists have been developed through interdisciplinary efforts during the past decade, and their approval for prostate cancer treatment has significantly improved survival and decreased prostate cancer-related death worldwide, particularly in patients with mCSPC and...